Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential use of the SaNOtize nasal spray vaccine as a treatment for covid-19.
The Medicines and Healthcare products Regulatory Agency (MHRA) is aware of the clinical trial in the United Kingdom for the SaNOtize nasal spray. However, no nasal sprays for the prevention of COVID-19 are currently licensed in the UK. The MHRA together with independent advisory groups, continues to review the emerging body of evidence regarding potential medicines for the prevention or treatment of COVID-19.